Pretreatment platelet-to-lymphocyte ratio (PLR) as a prognosticating indicator for gastric cancer patients receiving immunotherapy

BACKGROUND: Previous investigations suggest that systemic inflammation markers are able to provide prognostic value in several cancers. This study seeks to characterize the ability of pretreatment platelet-to-lymphocyte ratio (PLR) to prognosticate advanced or metastatic gastric cancer patients (AGC...

Descripción completa

Detalles Bibliográficos
Autores principales: Gou, Miaomiao, Zhang, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633881/
https://www.ncbi.nlm.nih.gov/pubmed/36326905
http://dx.doi.org/10.1007/s12672-022-00571-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633881/
https://www.ncbi.nlm.nih.gov/pubmed/36326905
http://dx.doi.org/10.1007/s12672-022-00571-5

Ejemplares similares